Skip to main content
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Subscribe
Articles
Nivolumab plus Chemotherapy as First-Line Treatment for Advanced Gastric Cancer/Gastroesophageal Junction Cancer/Esophageal Adenocarcinoma: Expanded Analysis from CheckMate 649
Rapid Reactions
Read More ›
Immune Checkpoint Inhibitors Do Not Increase Mortality in Patients with Cancer and COVID-19
Web Exclusives
,
AACR
Read More ›
Impact of COVID-19 on Cancer Screening and How We Can Get Back on Track
By
Sheryl A. Riley, RN, OCN, CMCN
Cancer Screening and COVID-19
,
Web Exclusives
Read More ›
Novel CAR T-Cell Therapy Shows Promise in Relapsed or Refractory Multiple Myeloma
By
Charlie Dawson
Web Exclusives
,
Multiple Myeloma
Read More ›
Intratumoral Administration of INT230-6 Improves Drug Diffusion and Uptake into Cancer Cells in Patients with Advanced Solid Tumors
Web Exclusives
,
Emerging Therapies
Read More ›
Intratumoral Administration of INT230-6 Improves Drug Diffusion and Uptake into Cancer Cells in Patients with Advanced Solid Tumors
Web Exclusives
,
Emerging Therapies
Read More ›
A Call to Focus on Financial Toxicity and Quality of Life in Genitourinary Malignancies
Web Exclusives
,
ASCO
Read More ›
ctDNA May Be a Biomarker for Postsurgery MRD Positivity and Relapse in Patients with NSCLC
Web Exclusives
,
Lung Cancer
,
AACR
Read More ›
ctDNA May Be a Biomarker for Postsurgery MRD Positivity and Relapse in Patients with NSCLC
Web Exclusives
,
FDA Approvals, News & Updates
Read More ›
Luspatercept Effective in Patients with Lower-Risk Myelodysplastic Syndromes
FDA Approvals, News & Updates
,
Web Exclusives
Read More ›
Page 2 of 62
1
2
3
4
5
